
Sinopharm Group Co. Ltd.
Sinopharm Group Co. Ltd. is a China-based company in the Healthcare sector with a market capitalisation of $6.2B. Its FinScore is 53/100; its highest-scoring layer is Value (69) and its lowest is Growth (29). The shares trade at 5.9x trailing earnings and are down 20% year to date.
Share price performance
About Sinopharm Group Co. Ltd.
www.sinopharmgroup.com.cnSinopharm Group Co. Ltd. is a prominent player in the People's Republic of China's healthcare market, specializing in the wholesale and retail of pharmaceuticals, medical devices, and related health products. The company's business activities are organized across four main divisions. Its Pharmaceutical Distribution segment supplies pharmaceutical goods to a wide range of clients, including hospitals, fellow distributors, retail pharmacies, and clinics. This division additionally offers extensive distribution, logistics, and value-added support to both domestic and international manufacturers and suppliers in the pharmaceutical and healthcare sectors. The Medical Devices segment is solely focused on the distribution of various medical equipment. Through its Retail Pharmacy division, Sinopharm manages and franchises a vast chain of drug stores, with an impressive 10,259 locations as of December 31, 2021. The "Other Business" segment is involved in the manufacturing and sale of pharmaceutical products, chemical reagents, and laboratory supplies. Beyond these core areas, the company also engages in property rental and management. It further distributes specialized items such as medical instruments, traditional Chinese herbal medicines, antibiotics, and biological products. Sinopharm provides a comprehensive array of services, including IT development, medicine and health consultations, investment services, import/export facilitation for goods and technology, various business and market information consulting, and the organization of conventions and exhibitions. Moreover, it oversees medical project investments, offers related consulting, and provides technological training. Notably, Sinopharm Group has established a strategic alliance with I-Mab to enhance its commercial capabilities and accelerate its market entry strategies. Founded in Shanghai, China, in 2003, Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- HQ
- China
- Fiscal year-end
- December
- Trading currency
- HKD
- Reporting currency
- CNY
- Fundamentals updated
- 5 days ago
- Market cap
- $6.2B
- Shares outstanding
- 3.1B
- P/E (TTM)
- 5.9x
- Dividend yield (TTM)
- 5.03%
- Beta (issuer)
- 0.46
- Revenue (latest FY)
- CN¥575.2B
Revenue breakdown
Revenue split not available
FinScore
As of 2026-10-19Snapshot
Ownership
Holder data is not available for this company yet.
Sign up or log in to see Analysis
Analysis for Sinopharm Group Co. Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for Sinopharm Group Co. Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for Sinopharm Group Co. Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for Sinopharm Group Co. Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for Sinopharm Group Co. Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for Sinopharm Group Co. Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.